Insider Transactions in Q2 2023 at Jasper Therapeutics, Inc. (JSPR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Jeetinder Singh Mahal Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,000
-3.04%
|
$9,000
$1.66 P/Share
|
|
Jun 13
2023
|
Jeetinder Singh Mahal Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+2.95%
|
$0
$0.71 P/Share
|
|
Apr 14
2023
|
Anna Louise French Director |
SELL
Open market or private sale
|
Direct |
7,000
-22.76%
|
$7,000
$1.48 P/Share
|
|
Apr 13
2023
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Direct |
9,075
-30.0%
|
$9,075
$1.49 P/Share
|
|
Apr 13
2023
|
William Lis Director |
SELL
Open market or private sale
|
Direct |
8,500
-12.15%
|
$8,500
$1.44 P/Share
|
|
Apr 12
2023
|
Jeetinder Singh Mahal Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,126
-11.45%
|
$37,126
$1.46 P/Share
|
|
Apr 12
2023
|
Ron Martell President, CEO and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
87,531
-17.29%
|
$87,531
$1.46 P/Share
|